IBALX
Price
$35.08
Change
-$0.33 (-0.93%)
Updated
Sep 6 closing price
RLBCX
Price
$34.59
Change
-$0.42 (-1.20%)
Updated
Sep 6 closing price
Ad is loading...

IBALX vs RLBCX

Header iconIBALX vs RLBCX Comparison
Open Charts IBALX vs RLBCXBanner chart's image
Transamerica Multi-Managed Balanced A
Price$35.08
Change-$0.33 (-0.93%)
VolumeN/A
CapitalizationN/A
American Funds American Balanced R3
Price$34.59
Change-$0.42 (-1.20%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
IBALX vs RLBCX Comparison Chart
Loading...
VS
IBALX vs. RLBCX commentary
Sep 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IBALX is a Buy and RLBCX is a Buy.

FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 228B vs. IBALX (1.3B). RLBCX pays higher dividends than IBALX: RLBCX (1.98) vs IBALX (1.43). IBALX was incepted earlier than RLBCX: IBALX (30 years) vs RLBCX (22 years). RLBCX is a more actively managed with annual turnover of: 171.00 vs. IBALX (33.00). RLBCX has a lower initial minimum investment than IBALX: RLBCX (250) vs IBALX (1000). RLBCX annual gain was more profitable for investors over the last year : 18.47 vs. IBALX (15.91). RLBCX return over 5 years is better than : 33.70 vs. IBALX (29.66).
IBALXRLBCXIBALX / RLBCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence30 years22 years-
Gain YTD11.88810.677111%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.3B228B1%
Annual Yield % from dividends1.431.9872%
Returns for 1 year15.9118.4786%
Returns for 3 years1.828.2522%
Returns for 5 years29.6633.7088%
Returns for 10 years46.5446.33100%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EA145.91-1.17
-0.80%
Electronic Arts
GLBS1.48-0.02
-1.25%
Globus Maritime Limited
FUL80.63-1.20
-1.47%
HB Fuller Company
SPRY11.75-0.18
-1.51%
ARS Pharmaceuticals
IPI23.28-0.36
-1.52%
Intrepid Potash